teaser
↓Article continues below this sponsored advert↓
↑Advertisement↑
It comes as no surprise but Sanofi-Aventis has withdrawn its marketing application to gain approval in the USA for its obesity drug Acomplia
Published on 2 July 2007
Sanofi pulls US rimonabant application
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
